Irbesartan + Ciprofibrate

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
84
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Hypertension

Conditions

Hypertension, Dyslipidemia

Trial Timeline

Feb 1, 2005 โ†’ Aug 1, 2007

About Irbesartan + Ciprofibrate

Irbesartan + Ciprofibrate is a approved stage product being developed by Bristol Myers Squibb for Hypertension. The current trial status is completed. This product is registered under clinical trial identifier NCT00350038. Target conditions include Hypertension, Dyslipidemia.

Hype Score Breakdown

Clinical
30
Activity
20
Company
9
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00350038ApprovedCompleted